Insider Trading activities of Revance Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Revance Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Revance Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of Revance Therapeutics, Inc. since 2005. The reporting company's ticker symbol is RVNC. The reporting company's CIK number is 1479290.
The total value of stock buying since 2005 is $661,360.
The total value of stock sales since 2005 is $7,026,526.
The total value of stock option exercises since 2005 is $1,024,881.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Revance Therapeutics, Inc. (RVNC).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-11 20,000 $543,960 10,000 $268,270 10,000 $87,000
2017-10 0 $0 18,826 $498,162 0 $0
2017-09 0 $0 7,600 $179,185 0 $0
2017-08 0 $0 22,800 $519,042 331 $844
2017-06 0 $0 0 $0 8,300 $21,165
2017-05 0 $0 33,793 $685,471 28,000 $212,849
2017-02 0 $0 11,037 $227,649 0 $0
2017-01 0 $0 12,000 $237,396 0 $0
2016-12 0 $0 12,000 $251,256 0 $0
2016-11 0 $0 12,000 $219,360 0 $0
2016-10 0 $0 12,000 $178,200 0 $0
2016-08 0 $0 0 $0 666 $4,395
2016-06 0 $0 1,000 $18,250 1,000 $8,700
2016-05 0 $0 1,000 $16,180 1,000 $8,700
2016-04 0 $0 1,000 $19,110 1,000 $8,700
2016-03 0 $0 1,000 $20,430 1,000 $8,700
2016-02 0 $0 1,000 $18,140 11,999 $51,596
2016-01 0 $0 2,000 $66,120 2,000 $17,400
2015-12 0 $0 0 $0 12,045 $30,714
2015-11 0 $0 7,753 $304,925 0 $0
2015-08 0 $0 3,000 $91,482 3,000 $26,099
2015-07 0 $0 3,000 $93,090 3,000 $22,950
2015-06 0 $0 3,500 $115,593 3,500 $23,100
2015-05 0 $0 3,000 $79,235 3,000 $19,800
2015-04 0 $0 2,000 $44,466 2,000 $13,200
2015-03 0 $0 2,500 $46,915 2,500 $16,500
2015-02 0 $0 1,000 $16,800 1,000 $4,575
2015-01 0 $0 1,500 $26,250 1,500 $3,825
2014-12 980 $17,380 1,500 $25,450 1,500 $3,825
2014-11 6,000 $100,020 1,000 $16,000 1,000 $2,550
2014-10 0 $0 2,000 $37,814 2,000 $5,099
2014-09 0 $0 99,713 $2,094,610 73,208 $422,595
2014-08 0 $0 25,000 $611,675 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Revance Therapeutics, Inc. insiders (RVNC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-11-07 Foley Mark J (Director) Buy 20,000 27.20 543,960
2017-11-07 Silvernail Lauren P (CFO, CBO & Secretary) Sale 10,000 26.83 268,270
2017-11-07 Silvernail Lauren P (CFO, CBO & Secretary) Option Ex 10,000 8.70 87,000
2017-10-18 Browne L Daniel (CEO and President) Sale 7,662 26.16 200,407
2017-10-12 Silvernail Lauren P (CFO, CBO & Secretary) Sale 11,164 26.67 297,755
2017-09-20 Browne L Daniel (CEO and President) Sale 7,600 23.58 179,185
2017-08-23 Browne L Daniel (CEO and President) Sale 22,800 22.77 519,042
2017-08-23 Browne L Daniel (CEO and President) Option Ex 331 2.55 844
2017-06-12 Browne L Daniel (CEO and President) Option Ex 8,300 2.55 21,165
2017-05-30 Browne L Daniel (CEO and President) Option Ex 5,000 2.55 12,750
2017-05-26 Silvernail Lauren P (CFO, CBO & Secretary) Option Ex 23,000 8.70 200,099
2017-05-24 Browne L Daniel (CEO and President) Sale 19,713 20.35 401,100
2017-05-22 Browne L Daniel (CEO and President) Sale 12,287 20.20 248,160
2017-05-22 Silvernail Lauren P (CFO, CBO & Secretary) Sale 1,793 20.20 36,211
2017-02-22 Browne L Daniel (CEO and President) Sale 11,037 20.63 227,649
2017-01-25 Browne L Daniel (CEO and President) Sale 12,000 19.78 237,396
2016-12-28 Browne L Daniel (CEO and President) Sale 12,000 20.94 251,256
2016-11-25 Browne L Daniel (CEO and President) Sale 12,000 18.28 219,360
2016-10-26 Browne L Daniel (CEO and President) Sale 12,000 14.85 178,200
2016-08-12 Joshi Abhay (Chief Operating Officer) Option Ex 666 6.60 4,395
2016-06-13 Ruegg Curtis (EVP, Technical Operations) Sale 1,000 18.25 18,250
2016-06-13 Ruegg Curtis (EVP, Technical Operations) Option Ex 1,000 8.70 8,700
2016-05-09 Ruegg Curtis (EVP, Technical Operations) Sale 1,000 16.18 16,180
2016-05-09 Ruegg Curtis (EVP, Technical Operations) Option Ex 1,000 8.70 8,700
2016-04-11 Ruegg Curtis (EVP, Technical Operations) Sale 1,000 19.11 19,110
2016-04-11 Ruegg Curtis (EVP, Technical Operations) Option Ex 1,000 8.70 8,700
2016-03-07 Ruegg Curtis (EVP, Technical Operations) Sale 1,000 20.43 20,430
2016-03-07 Ruegg Curtis (EVP, Technical Operations) Option Ex 1,000 8.70 8,700
2016-02-12 Byrnes Robert F (Director) Option Ex 10,999 3.90 42,896
2016-02-08 Ruegg Curtis (EVP, Technical Operations) Sale 1,000 18.14 18,140
2016-02-08 Ruegg Curtis (EVP, Technical Operations) Option Ex 1,000 8.70 8,700
2016-01-06 Ruegg Curtis (EVP, Technical Operations) Sale 2,000 33.06 66,120
2016-01-06 Ruegg Curtis (EVP, Technical Operations) Option Ex 2,000 8.70 17,400
2015-12-30 Browne L Daniel (CEO and President) Option Ex 12,045 2.55 30,714
2015-11-17 Bertolino Arthur Peter (EVP and Chief Medical Officer) Sale 7,753 39.33 304,925
2015-08-17 Ruegg Curtis (EVP, Technical Operations) Sale 3,000 30.49 91,482
2015-08-17 Ruegg Curtis (EVP, Technical Operations) Option Ex 3,000 8.70 26,099
2015-07-17 Ruegg Curtis (EVP, Technical Operations) Sale 3,000 31.03 93,090
2015-07-17 Ruegg Curtis (EVP, Technical Operations) Option Ex 3,000 7.65 22,950
2015-06-17 Ruegg Curtis (EVP, Technical Operations) Sale 3,000 33.53 100,593
2015-06-17 Ruegg Curtis (EVP, Technical Operations) Option Ex 3,000 6.60 19,800
2015-06-03 Ruegg Curtis (EVP, Technical Operations) Sale 500 30.00 15,000
2015-06-03 Ruegg Curtis (EVP, Technical Operations) Option Ex 500 6.60 3,300
2015-05-18 Ruegg Curtis (EVP, Technical Operations) Sale 2,500 26.69 66,735
2015-05-18 Ruegg Curtis (EVP, Technical Operations) Option Ex 2,500 6.60 16,500
2015-05-15 Ruegg Curtis (EVP, Technical Operations) Sale 500 25.00 12,500
2015-05-15 Ruegg Curtis (EVP, Technical Operations) Option Ex 500 6.60 3,300
2015-04-17 Ruegg Curtis (EVP, Technical Operations) Sale 2,000 22.23 44,466
2015-04-17 Ruegg Curtis (EVP, Technical Operations) Option Ex 2,000 6.60 13,200
2015-03-19 Ruegg Curtis (EVP, Technical Operations) Sale 500 20.00 10,000
2015-03-19 Ruegg Curtis (EVP, Technical Operations) Option Ex 500 6.60 3,300
2015-03-17 Ruegg Curtis (EVP, Technical Operations) Sale 1,500 18.61 27,915
2015-03-17 Ruegg Curtis (EVP, Technical Operations) Option Ex 1,500 6.60 9,900
2015-03-09 Ruegg Curtis (EVP, Technical Operations) Sale 500 18.00 9,000
2015-03-09 Ruegg Curtis (EVP, Technical Operations) Option Ex 500 6.60 3,300
2015-02-17 Ruegg Curtis (EVP, Technical Operations) Sale 1,000 16.80 16,800
2015-02-17 Ruegg Curtis (EVP, Technical Operations) Option Ex 1,000 4.58 4,575
2015-01-20 Ruegg Curtis (EVP R&D and Tech Operations) Sale 1,000 17.25 17,250
2015-01-20 Ruegg Curtis (EVP R&D and Tech Operations) Option Ex 1,000 2.55 2,550
2015-01-09 Ruegg Curtis (EVP R&D and Tech Operations) Sale 500 18.00 9,000
2015-01-09 Ruegg Curtis (EVP R&D and Tech Operations) Option Ex 500 2.55 1,275
2014-12-17 Ruegg Curtis (EVP R&D and Tech Operations) Sale 1,000 16.45 16,450
2014-12-17 Ruegg Curtis (EVP R&D and Tech Operations) Option Ex 1,000 2.55 2,550
2014-12-11 Silvernail Lauren P (CFO, Secretary & EVP Corp Dev.) Buy 980 17.73 17,380
2014-12-09 Ruegg Curtis (EVP R&D and Tech Operations) Sale 500 18.00 9,000
2014-12-09 Ruegg Curtis (EVP R&D and Tech Operations) Option Ex 500 2.55 1,275
2014-11-28 Browne L Daniel (CEO and President) Buy 6,000 16.67 100,020
2014-11-18 Ruegg Curtis (EVP R&D and Tech Operations) Sale 1,000 16.00 16,000
2014-11-18 Ruegg Curtis (EVP R&D and Tech Operations) Option Ex 1,000 2.55 2,550
2014-10-28 Ruegg Curtis (EVP R&D and Tech Operations) Sale 500 20.00 10,000
2014-10-28 Ruegg Curtis (EVP R&D and Tech Operations) Option Ex 500 2.55 1,275
2014-10-17 Ruegg Curtis (EVP R&D and Tech Operations) Sale 1,500 18.54 27,814
2014-10-17 Ruegg Curtis (EVP R&D and Tech Operations) Option Ex 1,500 2.55 3,824
2014-09-17 Waugh Jacob (Chief Scientific Officer) Sale 97,713 21.02 2,053,536
2014-09-17 Waugh Jacob (Chief Scientific Officer) Option Ex 69,380 5.91 410,035
2014-09-17 Ruegg Curtis (EVP R&D and Tech Operations) Sale 2,000 20.54 41,074
2014-09-17 Ruegg Curtis (EVP R&D and Tech Operations) Option Ex 1,162 2.55 2,963
2014-09-17 Byrnes Robert F (Director) Option Ex 2,666 3.60 9,597
2014-08-18 Waugh Jacob (Chief Scientific Officer) Sale 25,000 24.47 611,675

Insider trading activities including stock purchases, stock sales, and option exercises of RVNC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Revance Therapeutics, Inc. (symbol RVNC, CIK number 1479290) see the Securities and Exchange Commission (SEC) website.